What Do Cocaine Levels in Blood (ng/ml) Mean?

Understand what cocaine concentration (ng/ml) in a blood test means. Learn how these values are interpreted for clinical detection and forensic analysis.

A cocaine blood level reported in nanograms per milliliter tells you how much of the drug is circulating at the moment the sample was drawn, but interpreting what that number means for impairment, toxicity, or cause of death is far more complicated than reading a thermometer. Recreational users who feel high typically have blood concentrations somewhere in the range of roughly 150 to 1,500 ng/mL, while people who die from acute cocaine poisoning often have levels above about 3,000 ng/mL. Yet some people survive far higher concentrations than that, and some die at levels that look unremarkable. The number on a lab report is only the starting point; understanding it requires knowing how the sample was collected, what route of use was involved, how long after use the blood was drawn, and whether other substances were on board.

Typical Blood Concentration Ranges

In emergency-department patients who had recently used cocaine, the best-characterized data put average blood levels at roughly 270 ng/mL, though the spread was enormous, with some patients showing barely detectable levels and the highest surviving patient in one series reaching an estimated 36,000 ng/mL with minimal symptoms of toxicity. The same review estimated that recreational users generally peak somewhere between about 150 and 1,500 ng/mL, and that fatal acute poisoning is most likely when peak concentrations exceed roughly 3,000 ng/mL, although the quality of the data behind that estimate is limited.

Postmortem studies add more nuance. In one series of cocaine-attributed deaths, the average blood cocaine concentration was 908 ng/mL, but the range was dramatic: three cases exceeded 2,000 ng/mL, while ten others were at or below 700 ng/mL. In people who died of other causes but had incidentally used cocaine, the average was only 146 ng/mL. A separate autopsy study of 99 cases found that blood cocaine concentrations in cocaine-related deaths were statistically indistinguishable from concentrations in recreational users who died of unrelated causes, averaging about 1,120 ng/mL versus 487 ng/mL. Only the levels of cocaine’s main breakdown product, benzoylecgonine, were significantly higher in the toxicity group. That overlap is a central problem: a blood cocaine number by itself cannot reliably distinguish a lethal exposure from a recreational one.

Why the Same Number Can Mean Different Things

Several factors explain why a single ng/mL value is ambiguous. The first is tolerance. Someone who uses cocaine daily can function at blood levels that would cause seizures in a first-time user. The second is the route of administration. Intravenous and smoked cocaine produce high, sharp peaks in the blood within seconds to minutes, while intranasal use produces lower peaks that arrive more slowly. In one controlled study, a 32 mg intranasal dose produced lower plasma concentrations and weaker effects than a 25 mg intravenous dose or a 42 mg smoked dose, even though the intranasal dose was actually the largest by weight. The third factor is timing: cocaine is cleared fast. The drug’s half-life in plasma averages about 1.5 hours in occasional users. That means a blood draw taken even an hour after the peak could show a level half as high, making the original exposure look modest.

There is also an interesting wrinkle in how “high” a person feels at a given concentration. Research on intranasal cocaine found that at the same plasma level, people rated themselves as more intoxicated when their blood cocaine was still climbing than when it was falling. In other words, the subjective effect depends not just on the number but on whether you are on the way up or the way down. Acute tolerance sets in almost immediately after a single dose.

Chronic Users Eliminate Cocaine Differently

If you use cocaine regularly, the drug sticks around longer than published half-life numbers suggest. In heavy, active street users monitored during cessation, cocaine’s terminal half-life in plasma was about 3.8 hours, more than double the roughly 1.5-hour half-life seen in occasional users. Researchers concluded that regular use changes the way the body distributes and eliminates cocaine, likely because the drug accumulates in tissues over repeated dosing. A related controlled study using repeated oral doses found that the terminal elimination phase for cocaine and its metabolites stretched far beyond what single-dose studies would predict, with metabolite half-lives ranging from about 15 to 52 hours.

This matters for interpreting a blood result. A chronic user’s blood draw could show substantial cocaine and metabolite levels hours or even days after their last use, while an occasional user with the same pattern of use would already have undetectable levels. It also means that repeated binge use can push tissue concentrations to dangerous levels even if any single dose seems moderate.

What Happens When Alcohol Is Involved

Combining cocaine with alcohol produces a unique complication. The liver, instead of breaking cocaine down through its normal pathway, uses the ethanol to create a new compound called cocaethylene. This is the only known instance in which two recreational drugs combine inside the body to form an entirely new psychoactive substance. Cocaethylene has stimulant effects similar in strength to cocaine itself but lasts longer because its half-life is longer.

In practice, cocaethylene appears slowly in the blood and in amounts much smaller than cocaine itself. One controlled study found that cocaethylene’s appearance in plasma did not significantly alter cocaine’s subjective or cardiovascular effects at the concentrations measured. Still, the presence of cocaethylene complicates interpretation of toxicology reports because it extends the overall duration of stimulant activity in the blood and adds its own cardiac risks. If cocaethylene shows up on a blood panel alongside cocaine and benzoylecgonine, it confirms that the person was drinking alcohol at or near the time they used cocaine.

Why Postmortem Blood Levels Are Unreliable

Forensic pathologists treat postmortem cocaine concentrations with deep skepticism, and for good reason. After death, cocaine moves between tissues and blood in unpredictable ways depending on where in the body the sample is drawn. A study comparing blood collected soon after death with blood collected at autopsy found dramatic shifts: cocaine levels in subclavian vein blood generally decreased over the postmortem interval, while levels in heart, aorta, and femoral vein blood generally increased. The magnitude and direction of these changes varied from case to case. This postmortem redistribution means a blood cocaine level measured at autopsy can be substantially higher or lower than what was circulating at the moment of death.

On top of redistribution, cocaine degrades rapidly in unstored blood. Without a preservative like sodium fluoride, the drug breaks down so fast that it may be completely undetectable by the time a sample reaches the lab. In one experiment, cocaine in blood stored without sodium fluoride was undetectable within seven days at room temperature and at refrigerated temperatures, and had dropped by more than 80 percent even when frozen. With sodium fluoride added and the sample refrigerated, 86 to 91 percent of cocaine was still intact after 48 hours. This is why forensic labs rely heavily on benzoylecgonine, which is far more stable. A blood report showing high benzoylecgonine but no detectable cocaine usually means the sample was not preserved quickly enough, not that the person had stopped using long before the draw.

Cocaine Blood Levels and Driving Impairment

Courts and law enforcement want to know whether a given blood cocaine concentration means a person was too impaired to drive. The evidence is not encouraging for anyone hoping for a clean threshold. In one large study, drivers assessed as impaired by a clinical examiner had a median cocaine blood concentration of 100 ng/mL, while those assessed as not impaired had a median of 70 ng/mL. The difference was statistically significant, and there was a correlation between higher cocaine levels and greater impairment, but the relationship was weak. A broader review of the literature on drug-impaired driving reached a blunt conclusion: there is no clear, dose-dependent relationship between blood concentrations and impairment for most psychoactive drugs, cocaine included.

This stands in sharp contrast to alcohol, where blood alcohol concentration correlates reasonably well with the degree of impairment across most people. For cocaine, individual tolerance, the timing of the dose, the rising-versus-falling effect mentioned earlier, and the presence of metabolites all make it impossible to point to a number and say “this person was definitely impaired.” Some jurisdictions set per se limits anyway, treating any detectable cocaine or benzoylecgonine above a cutoff as grounds for a charge. Others require clinical evidence of impairment in addition to a positive blood result.

How Labs Measure Cocaine in Blood

Modern forensic and clinical labs measure cocaine and its metabolites using liquid chromatography coupled with tandem mass spectrometry. This technique can separately identify and quantify cocaine, benzoylecgonine, ecgonine methyl ester, norcocaine, cocaethylene, and other metabolites all in a single run. One of the trickiest parts of the analysis is that several cocaine metabolites have nearly identical masses, which means the lab’s instrument has to physically separate them before measurement. Careful adjustments to the separation method and the detector settings are needed to prevent one metabolite from masquerading as another.

This level of detail matters because the relative proportions of cocaine to its metabolites tell a story. A high cocaine-to-benzoylecgonine ratio suggests recent use, while a low ratio suggests the drug is well on its way to being cleared. The presence of cocaethylene, as mentioned earlier, signals concurrent alcohol use. The presence of anhydroecgonine methyl ester specifically points to smoked (crack) cocaine, since it is a pyrolysis product that forms when cocaine base is heated. A skilled toxicologist reads the full metabolite profile, not just the cocaine number, to reconstruct a plausible timeline.

Blood Versus Urine and Oral Fluid

Blood is the gold-standard matrix for estimating how much cocaine was circulating at a particular moment, but it has the shortest detection window. Urine testing picks up benzoylecgonine for days after last use and is the matrix with the widest detection window for cocaine. Oral fluid is increasingly popular in roadside testing because collection is easy and observed, but concentrations in saliva do not reliably predict what is happening in the blood. One study found reasonable correlation for benzoylecgonine levels between oral fluid and plasma but poor correlation for cocaine itself, with wide variability driven by unknown dosing times and amounts. The takeaway is that oral fluid and urine are useful for detecting whether someone has used cocaine, but you cannot convert those results into a meaningful blood level.

Genetic Variation in Cocaine Metabolism

Your body breaks cocaine down primarily using enzymes in the blood and liver, including one called butyrylcholinesterase. Some people carry genetic variants that produce a less active form of this enzyme, which means cocaine sticks around longer and hits harder at the same dose. Mouse models engineered to lack both butyrylcholinesterase and a related enzyme took about 2.5 times as long to recover from cocaine’s toxic effects compared to normal mice, showing prolonged hypothermia, hyperactivity, and seizure-like behavior. While the frequency of clinically significant enzyme deficiency in humans is not precisely known, the implication is that two people with identical blood cocaine levels could have very different risk profiles depending on how fast they can metabolize the drug. This is one more reason why a single ng/mL number, detached from context, tells you less than you might expect.

Cocaine and the Heart at Specific Concentrations

Cocaine’s most dangerous acute effect is on the heart, where it blocks sodium channels in cardiac muscle cells in a dose-dependent fashion. In laboratory experiments on isolated heart cells, cocaine at concentrations of roughly 6,000 to 12,000 ng/mL reduced the key sodium current by about 40 percent. Interestingly, adding alpha-1 acid glycoprotein, a protein naturally present in blood, reversed much of that blockade, restoring the sodium current substantially. This is a reminder that blood cocaine levels are always buffered by protein binding in a living person, and that isolated cell experiments can overstate the danger at a given concentration. Still, the relationship between cocaine level and sodium channel blockade helps explain why very high blood concentrations can trigger fatal arrhythmias, and why people with lower levels of circulating binding proteins may be at higher risk.

Placental Transfer and Fetal Exposure

For pregnant individuals, the question of what a cocaine blood level means extends to the fetus. Cocaine crosses the placenta rapidly by simple diffusion, at a rate roughly 80 percent as fast as a freely permeable reference substance. Neither the placenta nor the fetal side metabolizes cocaine to any meaningful degree during transit. To make matters worse, fetal cord blood binds cocaine more weakly than the mother’s blood does, meaning a higher fraction of the drug is free and active in fetal circulation. Cocaethylene and norcocaine cross equally fast, so if the mother was also drinking alcohol, the fetus gets exposed to both active compounds. The practical implication is that even modest maternal blood cocaine levels translate into meaningful fetal exposure, and the fetus is less equipped to buffer or break down the drug than the mother is.

Accidental Pediatric Exposure

Young children who accidentally ingest cocaine present a distinct clinical picture. In a review of 36 confirmed pediatric cocaine exposures, the median age was 18 months, and the most common clinical findings were rapid heart rate and seizures. Nearly 40 percent of these children required intensive care, and about a third experienced what toxicologists classify as a major effect, meaning serious, potentially life-threatening symptoms. Children have lower body weight, immature liver enzymes, and smaller protein-binding capacity than adults, all of which amplify the effective drug exposure at any given blood concentration. A level that would produce a mild buzz in a tolerant adult could trigger seizures in a toddler. This is one context where any detectable cocaine level in blood is clinically alarming, regardless of the specific number.